These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19682862)

  • 61. Comparison of the effects of fourth-generation fluoroquinolones on epithelial healing after photorefractive keratectomy.
    Shin JH; Lee HB; Park HY
    Cornea; 2010 Nov; 29(11):1236-40. PubMed ID: 20697276
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro antifungal activity of the fourth generation fluoroquinolones against Candida isolates from human ocular infections.
    Ozdek SC; Miller D; Flynn PM; Flynn HW
    Ocul Immunol Inflamm; 2006 Dec; 14(6):347-51. PubMed ID: 17162605
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of Brucellosis in Guinea Pigs via a Combination of Engineered Novel pH-Responsive Curcumin Niosome Hydrogel and Doxycycline-Loaded Chitosan-Sodium Alginate Nanoparticles: an In Vitro and In Vivo Study.
    Abo El-Ela FI; Hussein KH; El-Banna HA; Gamal A; Rouby S; Menshawy AMS; El-Nahass ES; Anwar S; Zeinhom MMA; Salem HF; Al-Sayed MAY; El-Newery HA; Shokier KAM; El-Nesr KA; Hosein HI
    AAPS PharmSciTech; 2020 Nov; 21(8):326. PubMed ID: 33206259
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro activities of six new fluoroquinolones against Brucella melitensis.
    Trujillano-Martín I; García-Sánchez E; Martínez IM; Fresnadillo MJ; García-Sánchez JE; García-Rodríguez JA
    Antimicrob Agents Chemother; 1999 Jan; 43(1):194-5. PubMed ID: 9869594
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Study of efficacy of modern fluoroquinolones against agent of glanders in experiments in vivo].
    Bondareva TA; Borisevich IV; Kalininskiĭ VB; Bondarev VP; Fomenkov OO
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (3):10-3. PubMed ID: 19623715
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of long-term ethanol feeding on efficacy of doxycycline plus rifampicin in the treatment of experimental brucellosis caused by Brucella melitensis in rats.
    Yumuk Z; Dundar V
    J Chemother; 2005 Oct; 17(5):509-13. PubMed ID: 16323439
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke.
    Meisel C; Prass K; Braun J; Victorov I; Wolf T; Megow D; Halle E; Volk HD; Dirnagl U; Meisel A
    Stroke; 2004 Jan; 35(1):2-6. PubMed ID: 14684767
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of early antibiotic treatment on the antibody response to cytoplasmic proteins of Brucella melitensis in mice.
    Bowden RA; Racaro GC; Baldi PC
    Clin Diagn Lab Immunol; 1999 May; 6(3):440-3. PubMed ID: 10225853
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Moxifloxacin treatment of tuberculosis.
    Gosling R; Gillespie S
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3642; author reply 3642-3. PubMed ID: 15328148
    [No Abstract]   [Full Text] [Related]  

  • 70. Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infections.
    Lueth P; Haughney SL; Binnebose AM; Mullis AS; Peroutka-Bigus N; Narasimhan B; Bellaire BH
    J Control Release; 2019 Jan; 294():288-297. PubMed ID: 30572034
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Efficacy of moxifloxacin (Avelox) in prophylaxis of infection in patients with profound neutropenia].
    Minenko SV; Dmitrieva NV; Sokolova EN; Zhukov NV; Ptushkin VV
    Antibiot Khimioter; 2004; 49(3):26-31. PubMed ID: 15344394
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Exposure to Brucella in the laboratory.
    Zervos MJ; Bostic G
    Lancet; 1997 Mar; 349(9052):651. PubMed ID: 9057755
    [No Abstract]   [Full Text] [Related]  

  • 73. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study.
    Khan W; Sullivan KL; McCann JW; Gonsalves CF; Sato T; Eschelman DJ; Brown DB
    AJR Am J Roentgenol; 2011 Aug; 197(2):W343-5. PubMed ID: 21785063
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Doxycycline-encapsulated solid lipid nanoparticles for the enhanced antibacterial potential to treat the chronic brucellosis and preventing its relapse: in vivo study.
    Hosseini SM; Farmany A; Abbasalipourkabir R; Soleimani Asl S; Nourian A; Arabestani MR
    Ann Clin Microbiol Antimicrob; 2019 Nov; 18(1):33. PubMed ID: 31706304
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
    Shinohara A; Yoshiki Y; Masamoto Y; Hangaishi A; Nannya Y; Kurokawa M
    Leuk Lymphoma; 2013 Apr; 54(4):794-8. PubMed ID: 22978686
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].
    Beloborodova NV; Popov DA; Vostrikova TIu; Bachinskaia EN; Kuznetsova ST
    Antibiot Khimioter; 2009; 54(1-2):25-6, 28-30. PubMed ID: 19499714
    [No Abstract]   [Full Text] [Related]  

  • 77. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin.
    Lang R; Shasha B; Rubinstein E
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2333-6. PubMed ID: 8285615
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents.
    Brouillard JE; Terriff CM; Tofan A; Garrison MW
    Pharmacotherapy; 2006 Jan; 26(1):3-14. PubMed ID: 16506347
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Fluoroquinolone prophylaxis: worth the cost?
    Haeusler GM; Slavin MA
    Leuk Lymphoma; 2013 Apr; 54(4):677-8. PubMed ID: 23035818
    [No Abstract]   [Full Text] [Related]  

  • 80. In vitro assay for the anti-Brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis.
    Motamedi H; Darabpour E; Gholipour M; Seyyed Nejad SM
    J Zhejiang Univ Sci B; 2010 Jul; 11(7):506-11. PubMed ID: 20593515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.